nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—ABCB1—melanoma	0.582	1	CbGaD
Candesartan—Pranlukast—NFKB1—melanoma	0.00758	0.534	CrCbGaD
Candesartan—Transaminases increased—Carmustine—melanoma	0.00407	0.0212	CcSEcCtD
Candesartan—Coagulopathy—Dactinomycin—melanoma	0.0034	0.0177	CcSEcCtD
Candesartan—Coagulopathy—Temozolomide—melanoma	0.00308	0.016	CcSEcCtD
Candesartan—Pranlukast—TNF—melanoma	0.00232	0.164	CrCbGaD
Candesartan—Oedema peripheral—Vemurafenib—melanoma	0.00232	0.012	CcSEcCtD
Candesartan—Malnutrition—Vemurafenib—melanoma	0.00205	0.0106	CcSEcCtD
Candesartan—Telmisartan—PPARG—melanoma	0.002	0.141	CrCbGaD
Candesartan—Back pain—Vemurafenib—melanoma	0.00198	0.0103	CcSEcCtD
Candesartan—Gastroenteritis—Temozolomide—melanoma	0.00196	0.0102	CcSEcCtD
Candesartan—Hyponatraemia—Carmustine—melanoma	0.00181	0.00938	CcSEcCtD
Candesartan—Cough—Vemurafenib—melanoma	0.00179	0.00928	CcSEcCtD
Candesartan—Myalgia—Vemurafenib—melanoma	0.00174	0.00906	CcSEcCtD
Candesartan—Arthralgia—Vemurafenib—melanoma	0.00174	0.00906	CcSEcCtD
Candesartan—Blood bilirubin increased—Docetaxel—melanoma	0.00168	0.00875	CcSEcCtD
Candesartan—Acute coronary syndrome—Bleomycin—melanoma	0.00157	0.00813	CcSEcCtD
Candesartan—Hypotension—Vemurafenib—melanoma	0.00156	0.00811	CcSEcCtD
Candesartan—Myocardial infarction—Bleomycin—melanoma	0.00156	0.00809	CcSEcCtD
Candesartan—Neutropenia—Dactinomycin—melanoma	0.00155	0.00807	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00152	0.00791	CcSEcCtD
Candesartan—Haematuria—Bleomycin—melanoma	0.00151	0.00786	CcSEcCtD
Candesartan—Sweating increased—Temozolomide—melanoma	0.00146	0.0076	CcSEcCtD
Candesartan—Neutropenia—Carmustine—melanoma	0.00145	0.00755	CcSEcCtD
Candesartan—Bronchitis—Temozolomide—melanoma	0.00145	0.0075	CcSEcCtD
Candesartan—Gastrointestinal disorder—Vemurafenib—melanoma	0.00144	0.0075	CcSEcCtD
Candesartan—Fatigue—Vemurafenib—melanoma	0.00144	0.00749	CcSEcCtD
Candesartan—Haemoglobin—Bleomycin—melanoma	0.00143	0.00744	CcSEcCtD
Candesartan—Haemorrhage—Bleomycin—melanoma	0.00143	0.0074	CcSEcCtD
Candesartan—Neutropenia—Temozolomide—melanoma	0.00141	0.0073	CcSEcCtD
Candesartan—Hyperglycaemia—Carmustine—melanoma	0.0014	0.00728	CcSEcCtD
Candesartan—Upper respiratory tract infection—Temozolomide—melanoma	0.0014	0.00725	CcSEcCtD
Candesartan—Agranulocytosis—Dactinomycin—melanoma	0.00138	0.00718	CcSEcCtD
Candesartan—Renal failure—Carmustine—melanoma	0.00136	0.00708	CcSEcCtD
Candesartan—Hyperglycaemia—Temozolomide—melanoma	0.00136	0.00704	CcSEcCtD
Candesartan—Hepatitis—Dactinomycin—melanoma	0.00133	0.00691	CcSEcCtD
Candesartan—Body temperature increased—Vemurafenib—melanoma	0.00132	0.00686	CcSEcCtD
Candesartan—Pharyngitis—Dactinomycin—melanoma	0.00132	0.00685	CcSEcCtD
Candesartan—Cardiac failure congestive—Docetaxel—melanoma	0.00127	0.00662	CcSEcCtD
Candesartan—Sinusitis—Temozolomide—melanoma	0.00126	0.00653	CcSEcCtD
Candesartan—Haemoglobin—Carmustine—melanoma	0.00125	0.0065	CcSEcCtD
Candesartan—Haemorrhage—Carmustine—melanoma	0.00124	0.00646	CcSEcCtD
Candesartan—Oedema peripheral—Carmustine—melanoma	0.00123	0.00637	CcSEcCtD
Candesartan—Renal impairment—Docetaxel—melanoma	0.00121	0.00631	CcSEcCtD
Candesartan—Haemoglobin—Temozolomide—melanoma	0.00121	0.00628	CcSEcCtD
Candesartan—Haemorrhage—Temozolomide—melanoma	0.0012	0.00625	CcSEcCtD
Candesartan—Hepatitis—Temozolomide—melanoma	0.0012	0.00625	CcSEcCtD
Candesartan—Asthenia—Vemurafenib—melanoma	0.0012	0.00623	CcSEcCtD
Candesartan—Pharyngitis—Temozolomide—melanoma	0.00119	0.0062	CcSEcCtD
Candesartan—Urinary tract disorder—Temozolomide—melanoma	0.00119	0.00617	CcSEcCtD
Candesartan—Oedema peripheral—Temozolomide—melanoma	0.00118	0.00615	CcSEcCtD
Candesartan—Cardiac failure—Docetaxel—melanoma	0.00118	0.00615	CcSEcCtD
Candesartan—Pruritus—Vemurafenib—melanoma	0.00118	0.00614	CcSEcCtD
Candesartan—Urethral disorder—Temozolomide—melanoma	0.00118	0.00612	CcSEcCtD
Candesartan—Hyponatraemia—Docetaxel—melanoma	0.00116	0.00603	CcSEcCtD
Candesartan—Anaemia—Bleomycin—melanoma	0.00115	0.00596	CcSEcCtD
Candesartan—Diarrhoea—Vemurafenib—melanoma	0.00114	0.00594	CcSEcCtD
Candesartan—Leukopenia—Bleomycin—melanoma	0.00111	0.00577	CcSEcCtD
Candesartan—Dizziness—Vemurafenib—melanoma	0.00111	0.00574	CcSEcCtD
Candesartan—Mental disorder—Carmustine—melanoma	0.00109	0.00566	CcSEcCtD
Candesartan—Malnutrition—Carmustine—melanoma	0.00108	0.00563	CcSEcCtD
Candesartan—Cough—Bleomycin—melanoma	0.00108	0.00562	CcSEcCtD
Candesartan—Anaemia—Dactinomycin—melanoma	0.00107	0.00556	CcSEcCtD
Candesartan—Vomiting—Vemurafenib—melanoma	0.00106	0.00552	CcSEcCtD
Candesartan—Chest pain—Bleomycin—melanoma	0.00106	0.00549	CcSEcCtD
Candesartan—Myalgia—Bleomycin—melanoma	0.00106	0.00549	CcSEcCtD
Candesartan—Rash—Vemurafenib—melanoma	0.00105	0.00547	CcSEcCtD
Candesartan—Mental disorder—Temozolomide—melanoma	0.00105	0.00547	CcSEcCtD
Candesartan—Dermatitis—Vemurafenib—melanoma	0.00105	0.00547	CcSEcCtD
Candesartan—Back pain—Carmustine—melanoma	0.00105	0.00544	CcSEcCtD
Candesartan—Headache—Vemurafenib—melanoma	0.00105	0.00544	CcSEcCtD
Candesartan—Malnutrition—Temozolomide—melanoma	0.00105	0.00544	CcSEcCtD
Candesartan—Leukopenia—Dactinomycin—melanoma	0.00104	0.00538	CcSEcCtD
Candesartan—Back pain—Temozolomide—melanoma	0.00101	0.00526	CcSEcCtD
Candesartan—Anaemia—Carmustine—melanoma	0.001	0.0052	CcSEcCtD
Candesartan—Nausea—Vemurafenib—melanoma	0.000993	0.00516	CcSEcCtD
Candesartan—Thrombocytopenia—Bleomycin—melanoma	0.000992	0.00515	CcSEcCtD
Candesartan—Myalgia—Dactinomycin—melanoma	0.000986	0.00512	CcSEcCtD
Candesartan—Angina pectoris—Docetaxel—melanoma	0.000973	0.00506	CcSEcCtD
Candesartan—Leukopenia—Carmustine—melanoma	0.00097	0.00504	CcSEcCtD
Candesartan—Anaemia—Temozolomide—melanoma	0.000968	0.00503	CcSEcCtD
Candesartan—Angioedema—Temozolomide—melanoma	0.000957	0.00497	CcSEcCtD
Candesartan—Hypotension—Bleomycin—melanoma	0.000947	0.00492	CcSEcCtD
Candesartan—Vertigo—Temozolomide—melanoma	0.000941	0.00489	CcSEcCtD
Candesartan—Leukopenia—Temozolomide—melanoma	0.000937	0.00487	CcSEcCtD
Candesartan—Hypertension—Carmustine—melanoma	0.000935	0.00486	CcSEcCtD
Candesartan—Neutropenia—Docetaxel—melanoma	0.000934	0.00485	CcSEcCtD
Candesartan—Palpitations—Temozolomide—melanoma	0.000925	0.00481	CcSEcCtD
Candesartan—Thrombocytopenia—Dactinomycin—melanoma	0.000925	0.0048	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Bleomycin—melanoma	0.000923	0.00479	CcSEcCtD
Candesartan—Myalgia—Carmustine—melanoma	0.000922	0.00479	CcSEcCtD
Candesartan—Chest pain—Carmustine—melanoma	0.000922	0.00479	CcSEcCtD
Candesartan—Anxiety—Carmustine—melanoma	0.000919	0.00477	CcSEcCtD
Candesartan—Cough—Temozolomide—melanoma	0.000914	0.00474	CcSEcCtD
Candesartan—Paraesthesia—Bleomycin—melanoma	0.00091	0.00472	CcSEcCtD
Candesartan—Hypertension—Temozolomide—melanoma	0.000904	0.00469	CcSEcCtD
Candesartan—Dyspnoea—Bleomycin—melanoma	0.000903	0.00469	CcSEcCtD
Candesartan—Myalgia—Temozolomide—melanoma	0.000891	0.00463	CcSEcCtD
Candesartan—Arthralgia—Temozolomide—melanoma	0.000891	0.00463	CcSEcCtD
Candesartan—Anxiety—Temozolomide—melanoma	0.000888	0.00461	CcSEcCtD
Candesartan—Acute coronary syndrome—Docetaxel—melanoma	0.000878	0.00456	CcSEcCtD
Candesartan—Renal failure—Docetaxel—melanoma	0.000876	0.00455	CcSEcCtD
Candesartan—Myocardial infarction—Docetaxel—melanoma	0.000873	0.00454	CcSEcCtD
Candesartan—Thrombocytopenia—Carmustine—melanoma	0.000866	0.0045	CcSEcCtD
Candesartan—Tachycardia—Carmustine—melanoma	0.000863	0.00448	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000861	0.00447	CcSEcCtD
Candesartan—Epistaxis—Docetaxel—melanoma	0.00084	0.00436	CcSEcCtD
Candesartan—Thrombocytopenia—Temozolomide—melanoma	0.000837	0.00434	CcSEcCtD
Candesartan—Agranulocytosis—Docetaxel—melanoma	0.000832	0.00432	CcSEcCtD
Candesartan—Hypotension—Carmustine—melanoma	0.000826	0.00429	CcSEcCtD
Candesartan—Hyperhidrosis—Temozolomide—melanoma	0.000826	0.00429	CcSEcCtD
Candesartan—Fatigue—Dactinomycin—melanoma	0.000815	0.00423	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Carmustine—melanoma	0.000806	0.00418	CcSEcCtD
Candesartan—Urticaria—Bleomycin—melanoma	0.000805	0.00418	CcSEcCtD
Candesartan—Haemoglobin—Docetaxel—melanoma	0.000804	0.00417	CcSEcCtD
Candesartan—Rhinitis—Docetaxel—melanoma	0.000802	0.00416	CcSEcCtD
Candesartan—Valsartan—ALB—melanoma	0.000801	0.0565	CrCbGaD
Candesartan—Body temperature increased—Bleomycin—melanoma	0.000801	0.00416	CcSEcCtD
Candesartan—Haemorrhage—Docetaxel—melanoma	0.0008	0.00415	CcSEcCtD
Candesartan—Hepatitis—Docetaxel—melanoma	0.0008	0.00415	CcSEcCtD
Candesartan—Paraesthesia—Carmustine—melanoma	0.000794	0.00412	CcSEcCtD
Candesartan—Pharyngitis—Docetaxel—melanoma	0.000794	0.00412	CcSEcCtD
Candesartan—Urinary tract disorder—Docetaxel—melanoma	0.00079	0.0041	CcSEcCtD
Candesartan—Dyspnoea—Carmustine—melanoma	0.000788	0.00409	CcSEcCtD
Candesartan—Oedema peripheral—Docetaxel—melanoma	0.000788	0.00409	CcSEcCtD
Candesartan—Somnolence—Carmustine—melanoma	0.000786	0.00408	CcSEcCtD
Candesartan—Urethral disorder—Docetaxel—melanoma	0.000784	0.00407	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Temozolomide—melanoma	0.000779	0.00404	CcSEcCtD
Candesartan—Gastrointestinal pain—Dactinomycin—melanoma	0.000773	0.00401	CcSEcCtD
Candesartan—Paraesthesia—Temozolomide—melanoma	0.000767	0.00398	CcSEcCtD
Candesartan—Gastrointestinal disorder—Carmustine—melanoma	0.000763	0.00396	CcSEcCtD
Candesartan—Dyspnoea—Temozolomide—melanoma	0.000762	0.00396	CcSEcCtD
Candesartan—Somnolence—Temozolomide—melanoma	0.00076	0.00395	CcSEcCtD
Candesartan—Dyspepsia—Temozolomide—melanoma	0.000752	0.00391	CcSEcCtD
Candesartan—Body temperature increased—Dactinomycin—melanoma	0.000747	0.00388	CcSEcCtD
Candesartan—Abdominal pain—Dactinomycin—melanoma	0.000747	0.00388	CcSEcCtD
Candesartan—Gastrointestinal disorder—Temozolomide—melanoma	0.000738	0.00383	CcSEcCtD
Candesartan—Fatigue—Temozolomide—melanoma	0.000737	0.00383	CcSEcCtD
Candesartan—Asthenia—Bleomycin—melanoma	0.000727	0.00377	CcSEcCtD
Candesartan—Gastrointestinal pain—Carmustine—melanoma	0.000723	0.00376	CcSEcCtD
Candesartan—Telmisartan—ABCB1—melanoma	0.000719	0.0507	CrCbGaD
Candesartan—Pruritus—Bleomycin—melanoma	0.000717	0.00372	CcSEcCtD
Candesartan—Mental disorder—Docetaxel—melanoma	0.000701	0.00364	CcSEcCtD
Candesartan—Abdominal pain—Carmustine—melanoma	0.000699	0.00363	CcSEcCtD
Candesartan—Body temperature increased—Carmustine—melanoma	0.000699	0.00363	CcSEcCtD
Candesartan—Gastrointestinal pain—Temozolomide—melanoma	0.000699	0.00363	CcSEcCtD
Candesartan—Malnutrition—Docetaxel—melanoma	0.000696	0.00362	CcSEcCtD
Candesartan—Urticaria—Temozolomide—melanoma	0.000679	0.00353	CcSEcCtD
Candesartan—Asthenia—Dactinomycin—melanoma	0.000678	0.00352	CcSEcCtD
Candesartan—Abdominal pain—Temozolomide—melanoma	0.000676	0.00351	CcSEcCtD
Candesartan—Body temperature increased—Temozolomide—melanoma	0.000676	0.00351	CcSEcCtD
Candesartan—Back pain—Docetaxel—melanoma	0.000674	0.0035	CcSEcCtD
Candesartan—Diarrhoea—Dactinomycin—melanoma	0.000646	0.00336	CcSEcCtD
Candesartan—Vomiting—Bleomycin—melanoma	0.000644	0.00334	CcSEcCtD
Candesartan—Anaemia—Docetaxel—melanoma	0.000644	0.00334	CcSEcCtD
Candesartan—Rash—Bleomycin—melanoma	0.000639	0.00332	CcSEcCtD
Candesartan—Dermatitis—Bleomycin—melanoma	0.000638	0.00331	CcSEcCtD
Candesartan—Asthenia—Carmustine—melanoma	0.000634	0.00329	CcSEcCtD
Candesartan—Leukopenia—Docetaxel—melanoma	0.000623	0.00324	CcSEcCtD
Candesartan—Palpitations—Docetaxel—melanoma	0.000615	0.0032	CcSEcCtD
Candesartan—Asthenia—Temozolomide—melanoma	0.000613	0.00318	CcSEcCtD
Candesartan—Cough—Docetaxel—melanoma	0.000608	0.00316	CcSEcCtD
Candesartan—Diarrhoea—Carmustine—melanoma	0.000605	0.00314	CcSEcCtD
Candesartan—Pruritus—Temozolomide—melanoma	0.000605	0.00314	CcSEcCtD
Candesartan—Nausea—Bleomycin—melanoma	0.000602	0.00312	CcSEcCtD
Candesartan—Hypertension—Docetaxel—melanoma	0.000601	0.00312	CcSEcCtD
Candesartan—Vomiting—Dactinomycin—melanoma	0.000601	0.00312	CcSEcCtD
Candesartan—Rash—Dactinomycin—melanoma	0.000596	0.00309	CcSEcCtD
Candesartan—Arthralgia—Docetaxel—melanoma	0.000593	0.00308	CcSEcCtD
Candesartan—Chest pain—Docetaxel—melanoma	0.000593	0.00308	CcSEcCtD
Candesartan—Myalgia—Docetaxel—melanoma	0.000593	0.00308	CcSEcCtD
Candesartan—Dizziness—Carmustine—melanoma	0.000585	0.00304	CcSEcCtD
Candesartan—Diarrhoea—Temozolomide—melanoma	0.000585	0.00304	CcSEcCtD
Candesartan—Dizziness—Temozolomide—melanoma	0.000565	0.00293	CcSEcCtD
Candesartan—Vomiting—Carmustine—melanoma	0.000562	0.00292	CcSEcCtD
Candesartan—Nausea—Dactinomycin—melanoma	0.000561	0.00291	CcSEcCtD
Candesartan—Rash—Carmustine—melanoma	0.000558	0.0029	CcSEcCtD
Candesartan—Dermatitis—Carmustine—melanoma	0.000557	0.00289	CcSEcCtD
Candesartan—Thrombocytopenia—Docetaxel—melanoma	0.000556	0.00289	CcSEcCtD
Candesartan—Tachycardia—Docetaxel—melanoma	0.000555	0.00288	CcSEcCtD
Candesartan—Headache—Carmustine—melanoma	0.000554	0.00288	CcSEcCtD
Candesartan—Vomiting—Temozolomide—melanoma	0.000543	0.00282	CcSEcCtD
Candesartan—Rash—Temozolomide—melanoma	0.000539	0.0028	CcSEcCtD
Candesartan—Dermatitis—Temozolomide—melanoma	0.000538	0.0028	CcSEcCtD
Candesartan—Headache—Temozolomide—melanoma	0.000535	0.00278	CcSEcCtD
Candesartan—Hypotension—Docetaxel—melanoma	0.000531	0.00276	CcSEcCtD
Candesartan—Nausea—Carmustine—melanoma	0.000525	0.00273	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Docetaxel—melanoma	0.000518	0.00269	CcSEcCtD
Candesartan—Paraesthesia—Docetaxel—melanoma	0.00051	0.00265	CcSEcCtD
Candesartan—Nausea—Temozolomide—melanoma	0.000508	0.00264	CcSEcCtD
Candesartan—Dyspnoea—Docetaxel—melanoma	0.000507	0.00263	CcSEcCtD
Candesartan—Somnolence—Docetaxel—melanoma	0.000505	0.00262	CcSEcCtD
Candesartan—Dyspepsia—Docetaxel—melanoma	0.0005	0.0026	CcSEcCtD
Candesartan—Gastrointestinal disorder—Docetaxel—melanoma	0.000491	0.00255	CcSEcCtD
Candesartan—Fatigue—Docetaxel—melanoma	0.00049	0.00254	CcSEcCtD
Candesartan—Gastrointestinal pain—Docetaxel—melanoma	0.000465	0.00241	CcSEcCtD
Candesartan—Body temperature increased—Docetaxel—melanoma	0.000449	0.00233	CcSEcCtD
Candesartan—Abdominal pain—Docetaxel—melanoma	0.000449	0.00233	CcSEcCtD
Candesartan—Asthenia—Docetaxel—melanoma	0.000408	0.00212	CcSEcCtD
Candesartan—Pruritus—Docetaxel—melanoma	0.000402	0.00209	CcSEcCtD
Candesartan—Losartan—ALB—melanoma	0.000391	0.0276	CrCbGaD
Candesartan—Diarrhoea—Docetaxel—melanoma	0.000389	0.00202	CcSEcCtD
Candesartan—Dizziness—Docetaxel—melanoma	0.000376	0.00195	CcSEcCtD
Candesartan—Losartan—ABCB1—melanoma	0.000373	0.0263	CrCbGaD
Candesartan—Vomiting—Docetaxel—melanoma	0.000361	0.00188	CcSEcCtD
Candesartan—Rash—Docetaxel—melanoma	0.000358	0.00186	CcSEcCtD
Candesartan—Dermatitis—Docetaxel—melanoma	0.000358	0.00186	CcSEcCtD
Candesartan—Headache—Docetaxel—melanoma	0.000356	0.00185	CcSEcCtD
Candesartan—Nausea—Docetaxel—melanoma	0.000338	0.00175	CcSEcCtD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	6.14e-05	0.000291	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SOCS1—melanoma	6.11e-05	0.00029	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAP2K1—melanoma	6.1e-05	0.000289	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—S100B—melanoma	6.1e-05	0.000289	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CD—melanoma	6.06e-05	0.000287	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	6.05e-05	0.000287	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLCB4—melanoma	6.05e-05	0.000287	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—VCAN—melanoma	6.02e-05	0.000286	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	6e-05	0.000285	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	5.96e-05	0.000283	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	5.83e-05	0.000277	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ERBB4—melanoma	5.83e-05	0.000277	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CB—melanoma	5.81e-05	0.000276	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN2B—melanoma	5.78e-05	0.000274	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PRKCA—melanoma	5.75e-05	0.000273	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ERCC2—melanoma	5.71e-05	0.000271	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.7e-05	0.000271	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC6A11—melanoma	5.68e-05	0.00027	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIP4K2A—melanoma	5.68e-05	0.00027	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LUM—melanoma	5.66e-05	0.000268	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PHGDH—melanoma	5.66e-05	0.000268	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLCB4—melanoma	5.65e-05	0.000268	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CD86—melanoma	5.59e-05	0.000265	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL8—melanoma	5.59e-05	0.000265	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	5.55e-05	0.000263	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HPSE—melanoma	5.55e-05	0.000263	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EDN1—melanoma	5.55e-05	0.000263	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	5.54e-05	0.000263	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTAP—melanoma	5.53e-05	0.000262	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	5.52e-05	0.000262	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.5e-05	0.000261	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CUBN—melanoma	5.45e-05	0.000258	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CSF2—melanoma	5.42e-05	0.000257	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FGF1—melanoma	5.42e-05	0.000257	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	5.41e-05	0.000257	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2—melanoma	5.34e-05	0.000253	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIP4K2A—melanoma	5.31e-05	0.000252	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC6A11—melanoma	5.31e-05	0.000252	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—E2F1—melanoma	5.3e-05	0.000252	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CB—melanoma	5.28e-05	0.000251	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	5.27e-05	0.00025	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SDHD—melanoma	5.26e-05	0.00025	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—BSG—melanoma	5.26e-05	0.00025	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CSPG4—melanoma	5.26e-05	0.00025	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PDGFRA—melanoma	5.25e-05	0.000249	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	5.22e-05	0.000248	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ITGB3—melanoma	5.2e-05	0.000247	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PRKCA—melanoma	5.2e-05	0.000247	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTAP—melanoma	5.17e-05	0.000245	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	5.1e-05	0.000242	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SPP1—melanoma	5.1e-05	0.000242	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPAM—melanoma	5.09e-05	0.000242	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	5.09e-05	0.000241	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP17A1—melanoma	5.08e-05	0.000241	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAP2K2—melanoma	5.08e-05	0.000241	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL8—melanoma	5.07e-05	0.000241	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	5.06e-05	0.00024	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	5.05e-05	0.00024	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.01e-05	0.000238	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	4.95e-05	0.000235	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PHGDH—melanoma	4.93e-05	0.000234	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LUM—melanoma	4.93e-05	0.000234	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2—melanoma	4.85e-05	0.00023	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HPSE—melanoma	4.83e-05	0.000229	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TERT—melanoma	4.83e-05	0.000229	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RAC1—melanoma	4.82e-05	0.000229	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GNA11—melanoma	4.8e-05	0.000228	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CUBN—melanoma	4.74e-05	0.000225	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—FASN—melanoma	4.7e-05	0.000223	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HIF1A—melanoma	4.62e-05	0.000219	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SLC5A5—melanoma	4.62e-05	0.000219	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PHGDH—melanoma	4.6e-05	0.000218	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LUM—melanoma	4.6e-05	0.000218	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	4.59e-05	0.000218	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SDHD—melanoma	4.58e-05	0.000217	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CSPG4—melanoma	4.58e-05	0.000217	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—BSG—melanoma	4.58e-05	0.000217	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HPSE—melanoma	4.51e-05	0.000214	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CG—melanoma	4.51e-05	0.000214	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CD44—melanoma	4.46e-05	0.000212	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GNAQ—melanoma	4.46e-05	0.000212	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPAM—melanoma	4.44e-05	0.000211	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CUBN—melanoma	4.43e-05	0.00021	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KDR—melanoma	4.42e-05	0.00021	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.37e-05	0.000207	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARG—melanoma	4.35e-05	0.000206	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	4.35e-05	0.000206	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PLA2G6—melanoma	4.33e-05	0.000206	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.33e-05	0.000205	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SDHD—melanoma	4.28e-05	0.000203	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—BSG—melanoma	4.28e-05	0.000203	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CSPG4—melanoma	4.28e-05	0.000203	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP1B1—melanoma	4.28e-05	0.000203	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FN1—melanoma	4.25e-05	0.000202	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	4.23e-05	0.000201	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOTCH1—melanoma	4.16e-05	0.000198	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPAM—melanoma	4.15e-05	0.000197	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	4.14e-05	0.000196	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	4.13e-05	0.000196	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CD80—melanoma	4.08e-05	0.000194	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KIT—melanoma	4.07e-05	0.000193	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CG—melanoma	4.07e-05	0.000193	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APC—melanoma	4.07e-05	0.000193	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—NRAS—melanoma	4.07e-05	0.000193	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EGF—melanoma	4.02e-05	0.000191	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CD—melanoma	3.96e-05	0.000188	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.94e-05	0.000187	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—melanoma	3.91e-05	0.000186	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.91e-05	0.000185	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAPK3—melanoma	3.9e-05	0.000185	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—VCAN—melanoma	3.89e-05	0.000185	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—BRAF—melanoma	3.83e-05	0.000182	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.77e-05	0.000179	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLA2G6—melanoma	3.77e-05	0.000179	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF1—melanoma	3.73e-05	0.000177	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAPK1—melanoma	3.71e-05	0.000176	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EGFR—melanoma	3.71e-05	0.000176	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.68e-05	0.000175	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAP2K1—melanoma	3.6e-05	0.000171	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.59e-05	0.00017	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CD—melanoma	3.58e-05	0.00017	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.55e-05	0.000169	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CA—melanoma	3.54e-05	0.000168	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLA2G6—melanoma	3.52e-05	0.000167	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ABCB1—melanoma	3.52e-05	0.000167	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—KRAS—melanoma	3.5e-05	0.000166	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.47e-05	0.000165	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CB—melanoma	3.45e-05	0.000164	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FGF2—melanoma	3.43e-05	0.000163	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—melanoma	3.42e-05	0.000162	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—VCAN—melanoma	3.39e-05	0.000161	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP17A1—melanoma	3.28e-05	0.000156	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PRKCA—melanoma	3.24e-05	0.000154	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.24e-05	0.000154	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CA—melanoma	3.22e-05	0.000153	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ERCC2—melanoma	3.21e-05	0.000153	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MDM2—melanoma	3.21e-05	0.000152	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	3.2e-05	0.000152	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—VCAN—melanoma	3.17e-05	0.00015	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ERBB2—melanoma	3.16e-05	0.00015	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CB—melanoma	3.12e-05	0.000148	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GNA11—melanoma	3.1e-05	0.000147	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—FASN—melanoma	3.03e-05	0.000144	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL8—melanoma	3e-05	0.000142	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3e-05	0.000142	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTEN—melanoma	2.98e-05	0.000142	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC5A5—melanoma	2.98e-05	0.000142	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—HRAS—melanoma	2.98e-05	0.000141	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.93e-05	0.000139	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN1B—melanoma	2.93e-05	0.000139	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—melanoma	2.9e-05	0.000137	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.89e-05	0.000137	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GNAQ—melanoma	2.88e-05	0.000137	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CD44—melanoma	2.88e-05	0.000137	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CASP3—melanoma	2.87e-05	0.000136	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—melanoma	2.86e-05	0.000136	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP17A1—melanoma	2.86e-05	0.000136	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—melanoma	2.85e-05	0.000135	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.82e-05	0.000134	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.8e-05	0.000133	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCND1—melanoma	2.79e-05	0.000133	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CTNNB1—melanoma	2.77e-05	0.000131	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP1B1—melanoma	2.76e-05	0.000131	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—melanoma	2.71e-05	0.000129	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN1A—melanoma	2.7e-05	0.000128	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GNA11—melanoma	2.7e-05	0.000128	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTEN—melanoma	2.7e-05	0.000128	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NFKB1—melanoma	2.68e-05	0.000127	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP17A1—melanoma	2.67e-05	0.000127	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.66e-05	0.000126	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	2.65e-05	0.000126	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—FASN—melanoma	2.64e-05	0.000125	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.63e-05	0.000125	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—melanoma	2.63e-05	0.000125	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	2.6e-05	0.000123	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC5A5—melanoma	2.6e-05	0.000123	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CG—melanoma	2.54e-05	0.00012	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GNA11—melanoma	2.52e-05	0.00012	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GNAQ—melanoma	2.51e-05	0.000119	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CD44—melanoma	2.51e-05	0.000119	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—FASN—melanoma	2.47e-05	0.000117	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—melanoma	2.45e-05	0.000116	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.44e-05	0.000116	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—melanoma	2.43e-05	0.000116	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC5A5—melanoma	2.43e-05	0.000115	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT3—melanoma	2.41e-05	0.000114	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP1B1—melanoma	2.41e-05	0.000114	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NRAS—melanoma	2.4e-05	0.000114	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GNAQ—melanoma	2.35e-05	0.000111	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CD44—melanoma	2.35e-05	0.000111	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK3—melanoma	2.3e-05	0.000109	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.3e-05	0.000109	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.28e-05	0.000108	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCB1—melanoma	2.27e-05	0.000108	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP1B1—melanoma	2.25e-05	0.000107	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MYC—melanoma	2.24e-05	0.000106	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CD—melanoma	2.23e-05	0.000106	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—melanoma	2.2e-05	0.000105	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK1—melanoma	2.19e-05	0.000104	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EGFR—melanoma	2.19e-05	0.000104	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CA—melanoma	2.11e-05	9.99e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PRKCA—melanoma	2.09e-05	9.93e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ERCC2—melanoma	2.08e-05	9.85e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KRAS—melanoma	2.07e-05	9.82e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.98e-05	9.42e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CB—melanoma	1.95e-05	9.23e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—melanoma	1.93e-05	9.15e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CA—melanoma	1.9e-05	9.02e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCB1—melanoma	1.85e-05	8.79e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—melanoma	1.84e-05	8.73e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PRKCA—melanoma	1.82e-05	8.66e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ERCC2—melanoma	1.81e-05	8.58e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HRAS—melanoma	1.76e-05	8.35e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.72e-05	8.16e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—melanoma	1.72e-05	8.16e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PRKCA—melanoma	1.7e-05	8.09e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ERCC2—melanoma	1.69e-05	8.02e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—melanoma	1.68e-05	7.99e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTEN—melanoma	1.68e-05	7.98e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CG—melanoma	1.64e-05	7.78e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—melanoma	1.58e-05	7.51e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—melanoma	1.55e-05	7.37e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CD—melanoma	1.44e-05	6.84e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CG—melanoma	1.43e-05	6.78e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—melanoma	1.42e-05	6.75e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.4e-05	6.64e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—melanoma	1.38e-05	6.54e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CG—melanoma	1.33e-05	6.33e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—melanoma	1.29e-05	6.11e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CB—melanoma	1.26e-05	5.96e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CD—melanoma	1.26e-05	5.96e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—melanoma	1.25e-05	5.91e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—melanoma	1.24e-05	5.88e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CA—melanoma	1.19e-05	5.63e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CD—melanoma	1.17e-05	5.57e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—melanoma	1.16e-05	5.5e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CB—melanoma	1.09e-05	5.19e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTEN—melanoma	1.09e-05	5.15e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—melanoma	1.08e-05	5.15e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CB—melanoma	1.02e-05	4.85e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—melanoma	1.01e-05	4.81e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—melanoma	9.69e-06	4.6e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTEN—melanoma	9.46e-06	4.49e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTEN—melanoma	8.84e-06	4.19e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CA—melanoma	7.66e-06	3.63e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CA—melanoma	6.67e-06	3.17e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—melanoma	6.26e-06	2.97e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CA—melanoma	6.23e-06	2.96e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—melanoma	5.45e-06	2.59e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—melanoma	5.09e-06	2.42e-05	CbGpPWpGaD
